Literature DB >> 17475643

Bovine papillomavirus type 1 infection is mediated by SNARE syntaxin 18.

Valerie Laniosz1, Kha C Nguyen, Patricio I Meneses.   

Abstract

Events that lead to viral infections include the binding of the virus to the target cells, internalization of the virus into the cells, and the ability of the viral genome to be expressed. These steps are mediated by cellular and viral proteins and are temporally regulated. The papillomavirus capsid consists of two virally encoded capsid proteins, L1 and L2. Much is known about the role of the major capsid protein L1 compared to what is known of the role of the L2 protein. We identified the interaction of the L2 protein with SNARE protein syntaxin 18, which mediates the trafficking of vesicles and their cargo between the endoplasmic reticulum, the cis-Golgi compartment, and possibly the plasma membrane. Mutations of L2 residues 41 to 44 prevented the interaction of L2 protein with syntaxin 18 in cotransfection experiments and resulted in noninfectious pseudovirions. In this paper, we describe that syntaxin 18 colocalizes with infectious bovine papillomavirus type 1 (BPV1) pseudovirions during infection but does not colocalize with the noninfectious BPV1 pseudovirions made with an L2 mutant at residues 41 to 44. We show that an antibody against BPV1 L2 residues 36 to 49 (alpha L2 36-49) binds to in vitro-generated BPV1 pseudoviral capsids and does not coimmunoprecipitate syntaxin 18- and BPV1 L2-transfected proteins. alpha L2 36-49 was able to partially or completely neutralize infection of BPV1 pseudovirions and genuine virions. These results support the dependence of syntaxin 18 during BPV1 infection and the ability to interfere with infection by targeting the L2-syntaxin 18 interaction and further define the infectious route of BPV1 mediated by the L2 protein.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17475643      PMCID: PMC1933340          DOI: 10.1128/JVI.00571-07

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  52 in total

1.  DNA-induced structural changes in the papillomavirus capsid.

Authors:  C Fligge; F Schäfer; H C Selinka; C Sapp; M Sapp
Journal:  J Virol       Date:  2001-08       Impact factor: 5.103

2.  HIV surveillance among female sex workers.

Authors:  P D Ghys; C Jenkins; E Pisani
Journal:  AIDS       Date:  2001-04       Impact factor: 4.177

Review 3.  HIV surveillance: a global perspective.

Authors:  Elizabeth Pisani; Stefano Lazzari; Neff Walker; Bernhard Schwartländer
Journal:  J Acquir Immune Defic Syndr       Date:  2003-02       Impact factor: 3.731

4.  Cross-neutralization of cutaneous and mucosal Papillomavirus types with anti-sera to the amino terminus of L2.

Authors:  Diana V Pastrana; Ratish Gambhira; Christopher B Buck; Yuk-Ying S Pang; Cynthia D Thompson; Timothy D Culp; Neil D Christensen; Douglas R Lowy; John T Schiller; Richard B S Roden
Journal:  Virology       Date:  2005-07-05       Impact factor: 3.616

5.  Syntaxin 18, a SNAP receptor that functions in the endoplasmic reticulum, intermediate compartment, and cis-Golgi vesicle trafficking.

Authors:  K Hatsuzawa; H Hirose; K Tani; A Yamamoto; R H Scheller; M Tagaya
Journal:  J Biol Chem       Date:  2000-05-05       Impact factor: 5.157

6.  Cell surface-binding motifs of L2 that facilitate papillomavirus infection.

Authors:  Rongcun Yang; Patricia M Day; William H Yutzy; Ken-Yu Lin; Chien-Fu Hung; Richard B S Roden
Journal:  J Virol       Date:  2003-03       Impact factor: 5.103

7.  Human papillomavirus types 16, 31, and 58 use different endocytosis pathways to enter cells.

Authors:  Latifa Bousarghin; Antoine Touzé; Pierre-Yves Sizaret; Pierre Coursaget
Journal:  J Virol       Date:  2003-03       Impact factor: 5.103

8.  L1 interaction domains of papillomavirus l2 necessary for viral genome encapsidation.

Authors:  M M Okun; P M Day; H L Greenstone; F P Booy; D R Lowy; J T Schiller; R B Roden
Journal:  J Virol       Date:  2001-05       Impact factor: 5.103

9.  Analysis of the infectious entry pathway of human papillomavirus type 33 pseudovirions.

Authors:  Hans-Christoph Selinka; Tzenan Giroglou; Martin Sapp
Journal:  Virology       Date:  2002-08-01       Impact factor: 3.616

Review 10.  Animal models of papillomavirus pathogenesis.

Authors:  M Saveria Campo
Journal:  Virus Res       Date:  2002-11       Impact factor: 3.303

View more
  19 in total

1.  Study of infectious virus production from HPV18/16 capsid chimeras.

Authors:  Horng-Shen Chen; Jennifer Bromberg-White; Michael J Conway; Samina Alam; Craig Meyers
Journal:  Virology       Date:  2010-07-03       Impact factor: 3.616

2.  The high risk HPV16 L2 minor capsid protein has multiple transport signals that mediate its nucleocytoplasmic traffic.

Authors:  Shahan Mamoor; Zeynep Onder; Balasubramanyam Karanam; Kihyuck Kwak; Jennifer Bordeaux; Lauren Crosby; Richard B S Roden; Junona Moroianu
Journal:  Virology       Date:  2011-12-06       Impact factor: 3.616

3.  Human papillomavirus L2 facilitates viral escape from late endosomes via sorting nexin 17.

Authors:  Martina Bergant Marušič; Michelle A Ozbun; Samuel K Campos; Michael P Myers; Lawrence Banks
Journal:  Traffic       Date:  2012-01-08       Impact factor: 6.215

4.  Human papillomavirus type 16 infection of human keratinocytes requires clathrin and caveolin-1 and is brefeldin a sensitive.

Authors:  Valerie Laniosz; Sarah A Dabydeen; Mallory A Havens; Patricio I Meneses
Journal:  J Virol       Date:  2009-06-03       Impact factor: 5.103

Review 5.  L2, the minor capsid protein of papillomavirus.

Authors:  Joshua W Wang; Richard B S Roden
Journal:  Virology       Date:  2013-05-17       Impact factor: 3.616

Review 6.  Viral entry mechanisms: human papillomavirus and a long journey from extracellular matrix to the nucleus.

Authors:  Martin Sapp; Malgorzata Bienkowska-Haba
Journal:  FEBS J       Date:  2009-12       Impact factor: 5.542

Review 7.  Developing vaccines against minor capsid antigen L2 to prevent papillomavirus infection.

Authors:  Balasubramanyam Karanam; Subhashini Jagu; Warner K Huh; Richard B S Roden
Journal:  Immunol Cell Biol       Date:  2009 May-Jun       Impact factor: 5.126

8.  Bovine papillomavirus type 1: from clathrin to caveolin.

Authors:  Valerie Laniosz; Kirsten A Holthusen; Patricio I Meneses
Journal:  J Virol       Date:  2008-04-16       Impact factor: 5.103

9.  The role of NH4Cl and cysteine proteases in Human Papillomavirus type 16 infection.

Authors:  Sarah A Dabydeen; Patricio I Meneses
Journal:  Virol J       Date:  2009-07-20       Impact factor: 4.099

10.  Concatenated multitype L2 fusion proteins as candidate prophylactic pan-human papillomavirus vaccines.

Authors:  Subhashini Jagu; Balasubramanyam Karanam; Ratish Gambhira; Sudha V Chivukula; Revathi J Chaganti; Douglas R Lowy; John T Schiller; Richard B S Roden
Journal:  J Natl Cancer Inst       Date:  2009-05-26       Impact factor: 13.506

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.